paroxysmal sympathetic hyperactivity and considerations
play

Paroxysmal Sympathetic Hyperactivity and Considerations for Rehabilitation Alphonsa Thomas DO Brain Injury Medicine Fellow JFK Johnson Rehabilitation Institute May 17, 2018 Methods Literature review of articles from 2007-2017 Online

0 downloads 10 Views 3,3 MB Size Report
  1. Paroxysmal Sympathetic Hyperactivity and Considerations for Rehabilitation Alphonsa Thomas DO Brain Injury Medicine Fellow JFK Johnson Rehabilitation Institute May 17, 2018

  2. Methods • Literature review of articles from 2007-2017 • Online databases used: PUBMED, MEDLINE, COCHRANE and CINAL • • Terms used: • Paroxysmal sympathetic hyperactivity, dysautonomia, brain injury, storming, traumatic brain injury, outcome and rehabilitation

  3. Paroxysmal Sympathetic Hyperactivity • Characteristic traits were first described by Wilder Penfield in 1929 • Initially thought to be from a seizure focus • Over 31 other names identified for the syndrome • Call for unified term came in 2007 by Alejandro Rabinstein, who suggested use of the term PSH

  4. Definition “A syndrome, recognized in a subgroup of survivors of severe acquired brain injury, of simultaneous, paroxysmal transient increases in sympathetic (elevated heart rate, blood pressure, respiratory rate, temperature, sweating) and motor (posturing) activity.” Baguley, et al. Paroxysmal Sympathetic Hyperactivity after Acquired Brain Injury: Consensus on Conceptual Definition, Nomenclature, and Diagnostic Criteria. Journal of Neurotrauma. 2014;31(17):1515-1520.

  5. Epidemiology Types of Brain Injury In PSH • 8-33% of acquired brain injuries develop PSH 5% 5% • Incidence of 15-33% in 10% severe TBI TBI Anoxic • Lasts about 18-162 days Stroke and resolves within a year Other 80%

  6. Pathophysiology • Several proposed mechanisms • No seizure activity was noted on electroencephalography and noted that the syndrome is not effectively treated with anticonvulsants • There is no specific lesion designated as the causative factor for the development of PSH, but rather the overall burden of the injury

  7. Pathophysiology cont... Sympathetic surge • • 40% increase from baseline in serum adrenocortical hormones • 200-300% increase in serum catecholamine levels during paroxysmal episodes - Fernandez-Ortega et al. Catecholamines and Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury. Journal of Neurotrauma. 2017;34(1), 109-114

  8. Systemic Effects Elevated catecholamine levels • Extracranial manifestations • Cardiac arrhythmia • Pulmonary edema • Immunosuppression • Focal myocytolysis and myocardial necrosis •

  9. Excitatory: Inhibitory Ratio (EIR) Model • Latest concept is the excitatory: inhibitory ratio (EIR) model • The model is not specific to PSH and takes into account several neurological disorders that can cause autonomic and muscular overactivity • 2 part disconnect theory

  10. EIR cont... • Disconnect theory • Injury of higher centers (cortex, diencephalon and upper brainstem) • Loss of inhibition over the now unopposed sympathetic outflow from the lower brainstem and spinal cord Loss of ability to modulate the afferent sensory • information processed by the spinal cord. • Spinal cord circuits to create a positive feedback loop or an amplification of non-noxious or mild noxious stimuli that result in allodynia • Allodynic tendency

  11. What is the diagnosis?

  12. Diagnosis • Diagnosis of exclusion! • No standard criteria or measure • Symptoms & Signs Tachycardia • Tachypnea • Hypertension • Fever • Diaphoresis • Posturing •

  13. Differential Diagnoses Most Common Causes Least Common Causes Constipation Heterotopic Ossification Urinary retention Neuropathic pain (ie: CRPS) Infection Fractures Wounds Deep venous thrombosis Respiratory Nephrolithiasis Metabolic derangements Cholelithiasis

  14. Urinary retention Sepsis PSH Hypoxia

  15. Key features of PSH • Features are paroxysmal in nature • Simultaneity of clinical features • Sympathetic overactivity to normally non-painful stimuli • Absence of intra-paroxysmal parasympathetic features during episodes • Features persist ≥ 3 consecutive days • Features persist ≥ 2 weeks post-injury • Features are persistent despite treatment of alternative differential diagnosis • Medication administered to decrease sympathetic features • Lack of alternative explanations • Antecedent acquired brain injury

  16. PSH-Assessment Measure • PSH-AM • Clinical tool devised to estimate the probability a patient has PSH and the severity of their symptoms • Helps to monitor and track patients through their recovery and response to treatments • Two components Clinical Features Scale (CFS) • Diagnosis Likelihood Tool (DLT) •

  17. Supportive Treatment • Avoid or treat possible triggers • Proper positioning • Pain management • Suctioning • Nutrition • Energy expenditure in PSH has been noted up to three times from baseline • Decreases in body weight as much as 25-29% in the acute period

  18. Treatment Category Medication IV sedatives Dexmedetomidine , Propofol α2 agonists Clonidine β-blockers Propranolol Opiods Morphine, Fentanyl Neuromodulators Baclofen, Gabapentin, Bromocriptine Peripherally Acting Muscle Relaxants Dantrolene Diazepam, Lorazepam, Clonezapam Benzodiazepines

  19. Acute PSH Episodes Send in the storm • troopers! Goal is to quiet the • sympathetic surge Rule out other causes • Few meds to keep in • mind Opioids • Propranolol •

  20. Outcomes There are a handful of studies that have looked into • outcome of PSH patients Type of brain injury matters • • Lower Glasgow Outcome Scale scores and functional independence measures compared to similar patients Greater need of enteral nutrition and tracheostomies • which lend itself toward further complications Higher DRS scores, disorders of consciousness, longer • LOS, and mortality in this patient group

  21. Publication Brain Injury Setting Incidence Mortality # of Cases with Length of stay Disability Rating Glasgow Outcome Functional Independence PSH (Hosp) Scale Scale Measure TBI ICU 29/343 8% Longer Higher Worse NA Higher 9 Mathew et al TBI ICU 16/79 20.3% NA NA NA NA NA 10 Lv et al TBI Rehab 13/39 33.3% Longer No significant difference* NA 11 Laxe et al No significant No significant difference difference TBI ICU 19/167 11% Longer NA NA NA NA 12 Hinson et al TBI ICU 6/79 8% Longer Worse NA NA 13 Baguley et al No significant difference TBI ICU 18/80 22.5% NA NA NA NA NA Fernandez-Ortega et 14 al TBI ICU 18/179 10.1% Longer NA NA NA Fernandez-Ortega et No significant difference 15 al TBI 9/76 11.8% NA NA NA NA NA 16 Hendricks et al Acute care Varied NICU 17/93 18% NA NA NA NA NA 4 Rabinstein et al TBI,SAH,ICH, anoxia Vegetative ICU 87/333 26.1% Longer NA Worse NA Higher 18 Dolce et al Varied Rehab 26/407 6.4% NA Higher NA NA Higher 6 Pozzi et al

  22. Rehabilitation • Multidisciplinary approach • Uncontrolled PSH episodes interfere with therapy and can cause long term consequences • Nursing and therapy staff can help point triggers • Identify parameters of when to hold therapy

  23. Key Takeaways • Severe brain injury can result in episodes of sympathetic hyperactivity • Nomenclature varies but PSH is rising as the preferred term • Diagnosis of exclusion • Several options for management • Negative impact on LOS, medical course, and functional outcome measures

  24. References - Baguley IJ. The excitatory:inhibitory ratio model (EIR model): An integrative explanation of acute autonomic overactivity syndromes. Medical Hypotheses. 2008;70(1):26-35. - Baguley IJ, Perkes IE, Fernandez-Ortega J-F, Rabinstein AA, Dolce G, Hendricks HT. Paroxysmal Sympathetic Hyperactivity after Acquired Brain Injury: Consensus on Conceptual Definition, Nomenclature, and Diagnostic Criteria. Journal of Neurotrauma. 2014;31(17):1515-1520. - Choi HA, Jeon S-B, Samuel S, Allison T, Lee K. Paroxysmal sympathetic hyperactivity after acute brain injury. Current Neurology and Neuroscience Reports. 2013;13:370. - Fernandez-Ortega, J., Baguley, I., Gates, T., Garcia-Caballero, M., Quesada-Garcia, J. and Prieto-Palomino, M. Catecholamines and Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury. Journal of Neurotrauma. 2017;34(1), 109-114 - Fernandez-Ortega JF, Prieto-Palomino MA, Garcia-Caballero M, Galeas-Lopez JL, Quesada-Garcia G, Baguley IJ. Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury: Clinical and Prognostic Implications. Journal of Neurotrauma. 2012;29(7):1364-1370. - Hoarau X, Richer E, Dehail P, Cuny E. A 10-year follow-up study of patients with severe traumatic brain injury and dysautonomia treated with intrathecal baclofen therapy. Brain Injury. 2012;26(7-8):927-940 - Laxe, S., Terré, R., León, D. and Bernabeu, M. (2013). How does dysautonomia influence the outcome of traumatic brain injured patients admitted in a neurorehabilitation unit?. Brain Injury, 27(12), pp.1383-1387.

Recommend Documents


attention deficit hyperactivity disorder pass 39 october
Attention-Deficit/Hyperactivity

Attention-Deficit/Hyperactivity Disorder PASS 39 October 29, 2018 Famous

methods to assess
methods to assess sympathetic nerve

Sympathetic activity and methods to assess sympathetic nerve activity Paul

sympathetic activity and functional sympatholysis
Sympathetic activity and functional

20-05-2019 Control of blood flow in skeletal muscle: Sympathetic activity and

case
Case 70 yo with longstanding

12/8/19 Should We Ablate Asymptomatic AF in a Young Patient? Pro Edward

disclosures
Disclosures for All paroxysmal AF

9/7/2012 Should Balloon Technologies be Used Disclosures for All paroxysmal

a d h d
A.D.H.D By Trevor Larson ADHD

A.D.H.D By Trevor Larson ADHD Overview ADHD stands for attention deficit

running with the devil
Running with the Devil: Mechanical

Running with the Devil: Mechanical Sympathetic Networking Todd L. Montgomery

a gender differentiated mr sort model for diagnosis aid
A gender-differentiated MR-Sort model

A gender-differentiated MR-Sort model for diagnosis aid of Attention Deficit

assessment and treatment of attention deficit
ASSESSMENT AND TREATMENT OF

ASSESSMENT AND TREATMENT OF ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER AND

sympathetic reaction
Sympathetic Reaction Prepared by

Insensitive Munitions Industry Contribution for the New STANAG-AOP 4396 Ed.

leading organizational spread in in im improvement
Leading Organizational Spread in in Im

Leading Organizational Spread in in Im Improvement Prevention of of

facilitators to nurses utilization of a nurse driven
Facilitators to Nurses Utilization of

What are the Barriers and Facilitators to Nurses Utilization of a Nurse

national facts you should know
National Facts You Should Know CAUTI is

Catheter Associated Urinary Tract Infections (CAUTI) TAKING PRE CAU-TI ONS

as possible james v mcdonald md mph
as Possible James V. McDonald MD, MPH

Prescribing for Pain as Painlessly as Possible James V. McDonald MD, MPH Chief

acute pain
Acute Pain Acute Pain Nurse Service

Aileen Marino Acute Pain Acute Pain Nurse Service March, 2019 New Service

pain management in ethiopia
Pain management in Ethiopia By Rediet

Pain management in Ethiopia By Rediet Shimeles Workneh M.D Addis Ababa

esmo summit middle east 2018
ESMO SUMMIT MIDDLE EAST 2018 Prostate

ESMO SUMMIT MIDDLE EAST 2018 Prostate Cancer: Case Discussion Dr Deborah

conus medullaris syndrome
Conus Medullaris Syndrome MOIN UD DIN

Conus Medullaris Syndrome MOIN UD DIN MBBS, MD SKZMDC Acute back pain

urinary continence amp management post stroke
Urinary Continence & Management

Urinary Continence & Management Post Stroke Incontinence and Stroke

how i ve made outpatient total hip replacement the rule
How Ive Made Outpatient Total Hip

How Ive Made Outpatient Total Hip Replacement the Rule and Not the Exception

promoting urinary continence in ltc
PROMOTING URINARY CONTINENCE IN LTC

PROMOTING URINARY CONTINENCE IN LTC Kelly Kruse RN APRN BC MS, Continence

ryan michaud md
Ryan Michaud, MD Advanced Pain Care,

Ryan Michaud, MD Advanced Pain Care, Austin TX Affiliate Faculty UT Dell